BIMEKIZUMAB for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 1,451 adverse event reports in the FDA FAERS database where BIMEKIZUMAB was used for Psoriasis.
Most Reported Side Effects for BIMEKIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Psoriatic arthropathy | 615 | 25.0% | 1 | 27 |
| Psoriasis | 400 | 16.3% | 1 | 97 |
| Drug ineffective | 293 | 11.9% | 1 | 42 |
| Inappropriate schedule of product administration | 238 | 9.7% | 4 | 56 |
| Injection site pain | 225 | 9.2% | 0 | 38 |
| Product dose omission issue | 163 | 6.6% | 0 | 40 |
| Off label use | 160 | 6.5% | 1 | 36 |
| Oral candidiasis | 146 | 5.9% | 0 | 18 |
| Fatigue | 138 | 5.6% | 0 | 23 |
| Therapy interrupted | 138 | 5.6% | 1 | 31 |
| Pneumonia | 118 | 4.8% | 1 | 37 |
| Incorrect dose administered | 115 | 4.7% | 0 | 19 |
| Hidradenitis | 108 | 4.4% | 1 | 36 |
| Headache | 104 | 4.2% | 0 | 21 |
| Ankylosing spondylitis | 94 | 3.8% | 0 | 1 |
Other Indications for BIMEKIZUMAB
Psoriatic arthropathy (612)
Hidradenitis (238)
Product used for unknown indication (213)
Ankylosing spondylitis (140)
Off label use (61)
Axial spondyloarthritis (43)
Rheumatoid arthritis (18)
Pustular psoriasis (5)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)